Dr. Ping's Story Links
New research results show that a non-estrogen drug called Ophena significantly improves symptoms of vaginal dryness and painful intercourse in postmenopausal women, raising hopes of an alterative to estrogen replacement therapy.
Vaginal dryness and painful intercourse, or dyspareunia, are two common symptoms of postmenopausal vulvovaginal atrophy -- thinning of the tissue and lining of the vulva and vagina. It affects up to 40% of postmenopausal women in the U.S.


"The best of all healing worlds -- modern Western medicine blended with centuries-old Oriental wisdom."